Search
Follicular Lymphoma Clinical Trials in United Kingdom
A listing of 7 Follicular Lymphoma clinical trials actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
1 - 7 of 7
Show Filters
Match to Clinical Trials
Access to cutting-edge treatments
Latest clinical trials
Find trials in your area
Search by Name
Filter by Condition
Follicular Lymphoma
Filter by Age
Filter by Type
Gender
Male
Female
Both
Type of Study
Interventional
Observational
Clinical Trial Phase
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
Unknown
There are currently 7 active clinical trials seeking participants for Follicular Lymphoma research studies. The states with the highest number of trials for Follicular Lymphoma participants are .
A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma (GOLSEEK-4)
Recruiting
The study is designed as a multicenter, randomized, open label Phase 3 study to compare the efficacy and safety of golcadomide in combination with rituximab vs investigator's choice in participants with relapsed/refractory follicular lymphoma who have received at least one line of prior systemic therapy.
The study is designed as a multicenter, randomized, open label Phase 3 study to compare the efficacy and safety of golcadomide in combination with rituximab vs investigator's choice in participants with relapsed/refractory follicular lymphoma who have received at least one line of prior systemic therapy. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
08/21/2025
Locations: Local Institution - 0225, Birmingham, Alabama +153 locations
Local Institution - 0225, Birmingham, Alabama
Local Institution - 0014, Mobile, Alabama
Alaska Oncology and Hematology, Anchorage, Alaska
Local Institution - 0215, Little Rock, Arkansas
Local Institution - 0072, Duarte, California
Local Institution - 0119, San Francisco, California
Local Institution - 0008, Jacksonville, Florida
Local Institution - 0214, Tampa, Florida
Local Institution - 0217, Tampa, Florida
Northwest Georgia Oncology Centers, a Service of Wellstar Cobb Hospital, Marietta, Georgia
Local Institution - 0245, Newnan, Georgia
Local Institution - 0240, Arlington Heights, Illinois
Local Institution - 0253, Iowa City, Iowa
Local Institution - 0243, Waukee, Iowa
Local Institution - 0216, Westwood, Kansas
Local Institution - 0218, Lexington, Kentucky
Local Institution - 0023, Baltimore, Maryland
Greater Baltimore Medical Center, Towson, Maryland
Local Institution - 0145, Boston, Massachusetts
Local Institution - 0244, Boston, Massachusetts
Local Institution - 0247, Boston, Massachusetts
Hattiesburg Clinic Hematology/Oncology, Hattiesburg, Mississippi
Local Institution - 0144, Providence, Rhode Island
Local Institution - 0237, Austin, Texas
Local Institution - 0212, Fort Worth, Texas
Local Institution - 0230, San Antonio, Texas
Local Institution - 0236, Tyler, Texas
Local Institution - 0238, Fairfax, Virginia
Hematology Oncology Associates of Fredericksburg, Fredericksburg, Virginia
Local Institution - 0146, Roanoke, Virginia
Local Institution - 0143, Vancouver, Washington
Local Institution - 0134, Westmead, New South Wales
Local Institution - 0132, Adelaide, South Australia
Local Institution - 0131, Hobart, Tasmania
Local Institution - 0128, Heidelberg, Victoria
Local Institution - 0198, Malvern, Victoria
Local Institution - 0127, Perth, Western Australia
Local Institution - 0224, Perth, Western Australia
Local Institution - 0159, Vitoria, Espírito Santo
Local Institution - 0088, Niterói, Rio De Janeiro
Local Institution - 0087, Porto Alegre, Rio Grande Do Sul
Local Institution - 0079, Sao Paulo, São Paulo
Local Institution - 0089, Rio de Janeiro, Not set
Local Institution - 0066, São Paulo, Not set
Local Institution - 0092, São Paulo, Not set
Local Institution - 0200, Victoria, British Columbia
Princess Margaret Cancer Centre, Toronto, Ontario
Local Institution - 0250, Québec, Quebec
Local Institution - 0192, Sherbrooke, Quebec
Local Institution - 0226, Sherbrooke, Quebec
Local Institution - 0154, Santiago, Región Metropolitana De Santiago
Local Institution - 0155, Santiago, Región Metropolitana De Santiago
Local Institution - 0153, Santiago, Región Metropolitana De Santiago
Local Institution - 0246, Beijing, Beijing
Local Institution - 0171, Beijing, Beijing
Local Institution - 0172, Fuzhou Fujian, Fujian
Local Institution - 0173, Guangzhou, Guangdong
Local Institution - 0241, Harbin, Heilongjiang
Local Institution - 0176, Wuhan, Hubei
Local Institution - 0175, Changsha, Hunan
Local Institution - 0235, Hohhot, Inner Mongolia
Local Institution - 0233, Suzhou, Jiangsu
Local Institution - 0178, Nanchang, Jiangxi
Local Institution - 0239, Changchun, Jilin
Local Institution - 0177, Changchun, Jilin
Local Institution - 0179, Shenyang, Liaoning
Local Institution - 0242, Shenyang, Liaoning
Local Institution - 0180, Jinan, Shandong
Local Institution - 0181, Shanghai, Shanghai
Local Institution - 0249, Shanghai, Shanghai
Local Institution - 0234, Sichuan, Sichuan
Local Institution - 0182, Tianjin, Tianjin
Local Institution - 0227, Tianjin, Tianjin
Local Institution - 0248, Kunming, Yunnan
Local Institution - 0184, Hangzhou, Zhejiang
Local Institution - 0174, Zhengzhou, Not set
Local Institution - 0151, Oulu, Pohjois-Pohjanmaa
Local Institution - 0152, Turku, Varsinais-Suomi
Local Institution - 0150, Helsinki, Not set
Local Institution - 0100, Pessac, Aquitaine
Local Institution - 0044, Saint-Cloud, Hauts-de-Seine
Local Institution - 0047, Montpellier, Languedoc-Roussillon
Local Institution - 0120, Nantes, Loire-Atlantique
Local Institution - 0048, Lille, Nord
Local Institution - 0042, Pierre-Bénite, Rhône
Local Institution - 0191, Paris, Not set
Local Institution - 0121, Toulouse, Not set
Local Institution - 0163, Ulm, Baden-Württemberg
Local Institution - 0161, Augsburg, Bayern
Local Institution - 0220, Göttingen, Niedersachsen
Local Institution - 0166, Dortmund, Nordrhein-Westfalen
Local Institution - 0193, Düsseldorf, Nordrhein-Westfalen
Local Institution - 0231, Münster, Nordrhein-Westfalen
Local Institution - 0232, Münster, Nordrhein-Westfalen
Local Institution - 0164, Homburg, Saarland
Local Institution - 0165, Chemnitz, Sachsen
Local Institution - 0222, Erfurt, Thüringen
Local Institution - 0167, Jena, Thüringen
Local Institution - 0187, Dresden, Not set
Local Institution - 0162, München, Not set
Local Institution - 0221, Wuerzburg, Not set
Local Institution - 0109, Athens, Attikí
Local Institution - 0107, Αthens, Attikí
Local Institution - 0110, Thessaloniki, Thessaloníki
Local Institution - 0197, Thessaloniki, Thessaloníki
Local Institution - 0111, Alexandroupolis, Not set
Local Institution - 0108, Ioannina, Ípeiros
Local Institution - 0142, New Delhi, Delhi
Local Institution - 0139, Bengaluru, Karnataka
Local Institution - 0141, Mumbai, Maharashtra
Local Institution - 0140, Hyderabad, Telangana
Local Institution - 0138, Hyderabad, Telangana
Local Institution - 0104, Bologna, Emilia-Romagna
Local Institution - 0101, Meldola, Emilia-Romagna
Local Institution - 0103, Rozzano, Milano
Local Institution - 0106, Pisa, Toscana
Local Institution - 0102, Alessandria, Not set
Local Institution - 0105, Napoli, Not set
Local Institution - 0157, Torino, Not set
Aiiku Hospital, Sapporo, Hokkaido
Japanease Red Cross Society Himeji Hospital, Himeji, Hyogo
Local Institution - 0201, Morioka, Iwate
University of Yamanashi Hospital, Chuo, Yamanashi
Local Institution - 0059, Seoul, Seoul-teukbyeolsi [Seoul]
Local Institution - 0060, Seoul, Seoul-teukbyeolsi [Seoul]
Local Institution - 0061, Seoul, Seoul-teukbyeolsi [Seoul]
Local Institution - 0058, Seoul, Not set
Local Institution - 0050, Amsterdam, Noord-Holland
Local Institution - 0046, Groningen, Not set
Local Institution - 0053, Utrecht, Not set
Local Institution - 0188, Warszawa, Mazowieckie
Local Institution - 0186, Kraków, Małopolskie
Local Institution - 0190, Gdynia, Pomorskie
Local Institution - 0185, Skórzewo, Wielkopolskie
Local Institution - 0189, Łódź, Łódzkie
Local Institution - 0099, Dammam, Ash Sharqīyah
Local Institution - 0054, Riyadh, Not set
Local Institution - 0052, Riyadh, Not set
Local Institution - 0158, Sabadell, Barcelona [Barcelona]
Local Institution - 0122, Santander, Cantabria
Local Institution - 0124, Madrid, Madrid, Comunidad De
Local Institution - 0125, Valencia, Valenciana, Comunitat
Local Institution - 0126, Granada, Not set
Local Institution - 0123, Madrid, Not set
Local Institution - 0195, Istanbul- Fatih, İstanbul
Local Institution - 0194, Ankara, Not set
Local Institution - 0196, Antalya, Not set
Local Institution - 0223, Mersin, Not set
Local Institution - 0251, Abu Dhabi, Abū Z̧aby
Local Institution - 0252, Abu Dhabi, Abū Z̧aby
Norfolk and Norwich University Hospitals NHS Foundation Trust, Cringleford, England
Kent and Canterbury Hospital, Canterbury, Kent
Local Institution - 0213, London, London, City Of
Local Institution - 0149, Manchester, Not set
Conditions: Follicular Lymphoma
A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies
Recruiting
Study consists of two main parts to explore BGB-16673 recommended dosing, a Phase 1 monotherapy dose finding comprised of monotherapy dose escalation and monotherapy safety expansion of selected doses, and a Phase 2 (expansion cohorts)
Study consists of two main parts to explore BGB-16673 recommended dosing, a Phase 1 monotherapy dose finding comprised of monotherapy dose escalation and monotherapy safety expansion of selected doses, and a Phase 2 (expansion cohorts) Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
08/19/2025
Locations: University of Alabama At Birmingham Hospital, Birmingham, Alabama +116 locations
University of Alabama At Birmingham Hospital, Birmingham, Alabama
Western Regional Medical Center, Llc, Goodyear, Arizona
Mayo Clinic Phoenix, Phoenix, Arizona
Honor Health Research Institute, Scottsdale, Arizona
University of Arizona Cancer Center, Tucson, Arizona
University of California San Diego (Ucsd) Moores Cancer Center, La Jolla, California
Stanford Medicine, Palo Alto, California
UCLA Santa Monica Cancer Care, Santa Monica, California
Uchealth North, Fort Collins, Colorado
Mayo Clinic Jacksonville, Jacksonville, Florida
Mount Sinai Comprehensive Cancer Center, Miami Beach, Florida
Tampa General Hospital Cancer Institute, Tampa, Florida
Augusta University, Augusta, Georgia
Southeastern Regional Medical Center, Newnan, Georgia
Midwestern Regional Medical Center, Zion, Illinois
University of Iowa Hospitals and Clinics, Iowa City, Iowa
Norton Cancer Institute Pavilion, Louisville, Kentucky
Mary Bird Perkins Cancer Center, Baton Rouge, Louisiana
American Oncology Partners of Maryland Pa, Bethesda, Maryland
Dana Farber Cancer Institute, Boston, Massachusetts
Karmanos Cancer Institute, Detroit, Michigan
Mayo Clinic Rochester, Rochester, Minnesota
Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada
Roswell Park Comprehensive Cancer Center, Buffalo, New York
Columbia University Medical Center, New York, New York
Weill Cornell Medical College Newyork Presbyterian Hospital, New York, New York
Memorial Sloan Kettering Cancer Center Mskcc, New York, New York
Tennesse Oncology Chattanooga, Chattanooga, Tennessee
Tennessee Oncology, Pllc Nashville, Nashville, Tennessee
Md Anderson Cancer Center, Houston, Texas
Virginia Commonwealth University Massey Cancer Center, Richmond, Virginia
Fred Hutchinson Cancer Research Center, Seattle, Washington
Concord Repatriation General Hospital, Concord, New South Wales
Calvary Mater Newcastle, Waratah, New South Wales
Princess Alexandra Hospital, Woolloongabba, Queensland
St Vincents Hospital Melbourne, Fitzroy, Victoria
Peninsula Private Hospital, Frankston, Victoria
Austin Health, Heidelberg, Victoria
Peter Maccallum Cancer Centre, Melbourne, Victoria
The Alfred Hospital, Melbourne, Victoria
Linear Clinical Research, Nedlands, Western Australia
Perth Blood Institute, West Perth, Western Australia
Hospital Sirio Libanes Brasilia, Brasilia, Not set
Instituto de Pesquisa Em Saude Da Universidade de Caxias Do Sul, Caxias do Sul, Not set
Hospital Erasto Gaertner, Curitiba, Not set
Centro Gaucho Integrado de Oncologia Hospital Mae de Deus, Porto Alegre, Not set
Hospital Ernesto Dornelles, Porto Alegre, Not set
Real E Benemerita Associacao Portuguesa de Sao Paulo, Sao Paulo, Not set
Hospital Alemao Oswaldo Cruz, Sao Paulo, Not set
Hospital Nove de Julho Dasa, Sao Paulo, Not set
Instituto Dor de Pesquisa E Ensino Sao Paulo, Sao Paulo, Not set
Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein, Sao Paulo, Not set
Hospital Santa Rita de Cassia Afecc, Vitoria, Not set
Cross Cancer Institute, Edmonton, Alberta
British Columbia Cancer Agency the Vancouver Centre, Vancouver, British Columbia
Princess Margaret Cancer Centre, Toronto, Ontario
Arthur Je Child Comprehensive Cancer Centre, Calgary, Not set
Chu de Quebec Universite Laval, Hopital de Lenfant Jesus, Centre Integre de Cancerologie (Cic), Quebec, Not set
Centre de Lutte Contre Le Cancer Institut Bergonie, Bordeaux, Not set
Hopital Estaing, Clermontferrand, Not set
Chu Henri Mondor, Creteil, Not set
Hopital Claude Huriez Chu Lille, Lille, Not set
Centre Leon Berard, Lyon Cedex, Not set
Institut Paoli Calmettes, Marseille, Not set
Chu Montpellier Hopital Saint Eloi, Montpellier, Not set
Hopital de La Pitie Salpetriere, Paris, Not set
Centre Henri Becquerel, Rouen Cedex, Not set
Arensia Exploratory Medicine Llc, Tbilisi, Not set
Universitatsklinikum Carl Gustav Carus An Der Technischen Universitat Dresden, Dresden, Not set
Uniklinik Koeln (Aoer), Koln, Not set
Universitares Krebszentrum Leipzig, Leipzig, Not set
Universitaetsklinikum Schleswig Holstein Campus Luebeck, Luebeck, Not set
Klinikum Johannes Gutenberg Universitaet Mainz, Mainz, Not set
Klinikum Grosshadern Ludwig Maximilians Universitat Munchen, Munchen, Not set
Universitaetsklinikum Ulm, Ulm, Not set
Policlinico Sorsola Malpighi, Aou Di Bologna, Bologna, Not set
Ospedale San Raffaele, Milano, Not set
Istituto Europeo Di Oncologia, Milano, Not set
Niguarda Cancer Center Division of Hematology, Milano, Not set
Fondazione Policlinico Universitario Agostino Gemelli, Roma, Not set
Centroricerche Cliniche Di Verona Srl, Verona, Not set
Aichi Cancer Center Hospital Clinical Oncology, Nagoya, Aichi
Chiba Cancer Center, Chibashi, Chiba
National Cancer Center Hospital East, Kashiwa, Chiba
Cancer Institute Hospital of Jfcr, Kotoku, Tokyo
Yokohama Municipal Citizens Hospital, YokohamaShi, Not set
Inje University Busan Paik Hospital, BusanjinGu, Busan Gwang'yeogsi
Pusan National University Hospital, SeoGu, Busan Gwang'yeogsi
Samsung Medical Center, GangnamGu, Seoul Teugbyeolsi
The Catholic University of Korea, Seoul St Marys Hospital, SeochoGu, Seoul Teugbyeolsi
Severance Hospital Yonsei University Health System, SeodaemunGu, Seoul Teugbyeolsi
Seoul National University Hospital, Seoul, Seoul Teugbyeolsi
Asan Medical Center, SongpaGu, Seoul Teugbyeolsi
The Institute of Oncology, Arensia Exploratory Medicine, Chisinau, Not set
Hospital Universitario Vall Dhebron, Barcelona, Not set
Hospital de La Santa Creu I Sant Pau, Barcelona, Not set
Hospital General Universitario Gregorio Maranon, Madrid, Not set
Md Anderson Cancer Center Madrid Spain, Madrid, Not set
Hospital Universitario Fundacion Jimenez Diaz, Madrid, Not set
Hospital Universitario La Paz, Madrid, Not set
Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda, Not set
Hospital Clinico Universitario de Valencia, Valencia, Not set
Sahlgrenska University Hospital Hematology, Goteborg, Not set
Karolinska Universitetssjukhuset Solna, Stockholm, Not set
Uppsala Akademiska Sjukhus, Uppsala, Not set
Ankara University, Abidinpaa, Not set
Dr Abdurrahman Yurtaslan Research and Training Hospital, Ankara, Not set
Dokuz Eylul University, Balcova, Not set
Erciyes University, Kayseri, Not set
Sakarya Training and Research Hospital, Sakarya, Not set
Ondokuz Mayis University, Samsun, Not set
Edinburgh Cancer Centre, Edinburgh, Not set
Churchill Hospital Oxford University Hospital Nhs Trust, Headington, Not set
St Jamess University Hospital, Leeds, Not set
Freeman Hospital, NewCastle Upon Tyne, Not set
Nottingham University Hospitals Nhs Trust, Nottingham, Not set
Derriford Hospital, Plymouth, Not set
Conditions: B-cell Malignancy, Marginal Zone Lymphoma, Follicular Lymphoma, Non-hodgkin Lymphoma, Waldenström Macroglobulinemia, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma, Diffuse Large B Cell Lymphoma
A Long-term Extension Study of PCI-32765 (Ibrutinib)
Recruiting
The purpose of this study is to collect long-term safety and efficacy data for participants treated with ibrutinib and to provide ongoing access to ibrutinib for participants who are currently enrolled in ibrutinib studies that have been completed according to the parent protocol, are actively receiving treatment with ibrutinib, and who continue to benefit from ibrutinib treatment.
The purpose of this study is to collect long-term safety and efficacy data for participants treated with ibrutinib and to provide ongoing access to ibrutinib for participants who are currently enrolled in ibrutinib studies that have been completed according to the parent protocol, are actively receiving treatment with ibrutinib, and who continue to benefit from ibrutinib treatment. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
08/15/2025
Locations: City of Hope Cancer Center, Duarte, California +173 locations
City of Hope Cancer Center, Duarte, California
University of California San Diego Medical Center, La Jolla, California
University of California Los Angeles, Los Angeles, California
St. Joseph Hospital Center for Cancer Prevention and Treatment, Orange, California
Stanford University Medical Center, Stanford, California
Stanford University, Stanford, California
Norwalk Medical Group, Norwalk, Connecticut
Northwest Georgia Oncology Centers PC, Marietta, Georgia
Northwestern University Hospital, Chicago, Illinois
Indiana University, Goshen, Indiana
Kansas University Medical Center, Westwood, Kansas
Louisville Oncology Suburban - Norton Cancer Institute, Louisville, Kentucky
Dana Farber Cancer Center, Boston, Massachusetts
University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan
Battle Creek Health Systm, Battle Creek, Michigan
Karmanos Cancer Institute - Wayne State University, Detroit, Michigan
Washington University, Saint Louis, Missouri
Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire
Hackensack University Medical Center, Hackensack, New Jersey
Weill Medical College of Cornell University, New York, New York
Memorial Sloan-Kettering Cancer Center, New York, New York
Southeastern Medical Oncology Center, Goldsboro, North Carolina
The Ohio State University- James Cancer Hospital, Columbus, Ohio
Willamette Valley Cancer Center, Eugene, Oregon
Kaiser Permanente, Portland, Oregon
University of Pennsylvania Medical Center, Philadelphia, Pennsylvania
Avera Medical Group, Sioux Falls, South Dakota
MD Anderson Cancer Center - University of Texas, Houston, Texas
University of Virginia, Charlottesville, Virginia
University of Washington, Seattle, Washington
West Virginia University, Morgantown, West Virginia
University of Wisconsin Carbone Cancer Center - Wisconsin Institute for Medical Research, Madison, Wisconsin
CEMIC Saavedra, Ciudad Autonoma Buenos Aires, Not set
Fundaleu, Ciudad de Buenos Aires, Not set
Royal Adelaide Hospital, Adelaide, Not set
John Fawkner Cancer Trial Centre, Coburg, Not set
Concord Hospital, Concord, Not set
Austin Health, Heidelberg, Not set
Peter MacCallum Cancer Institute, Melbourne, Not set
Royal Perth Hospital, Perth, Not set
Alfred Hospital, Prahran, Not set
Adventist Health Care Limited trading as San Clinical Trials Unit, Wahroonga, Not set
UZA, Antwerp, Not set
A.Z. Sint Jan, Brugge, Not set
UCL - Saint Luc, Brussels, Not set
UZ Gent - departement oncologie, Gent, Not set
UZ Leuven Gasthuisberg, Leuven, Not set
UCL Mont-Godinne, Yvoir, Not set
Ministerio da Saude Instituto Nacional do Cancer, Rio De Janeiro, Not set
Santa Casa da Misericórdia da Bahia - Hospital Santa Isabel, Salvador, Not set
Instituto de Ensino e Pesquisa São Lucas, Sao Paulo, Not set
Jewish General Hospital, Montreal, Quebec
Peking University People s Hospital, Beijing, Not set
Peking University Third Hospital, Beijing, Not set
Peking University First Hospital, Beijing, Not set
West China Hospital Sichuan University, Chengdu, Not set
Fujian Medical University, Fuzhou, Not set
Sun Yat-sen University Cancer Hospital, Guangzhou, Not set
Zhejiang University First Hospital, Hangzhou, Not set
Ruijin Hospital, Shanghai, Not set
Tangdu hospital the Fourth Military Medical, Shanxi, Not set
The First Affliated Hospital of Soochow University, Suzhou, Not set
The Institute of Hematological disease, Tianjin, Not set
Wuhan Union Hospital, Wuhan, Not set
Fundacion Santa Fe, Bogota, Not set
Fundacion Oftalmologica de Santander - FOSCAL, Floridablanca, Not set
Fakultni nemocnice Brno, Interni hematologicka a onkologicka klinika, Brno, Not set
Fakultni nemocnice Kralovske Vinohrady - Interni hematologicka klinika, Praha 10, Not set
Vseobecna fakultni nemocnice v Praze - I. interni klinika - klinika hematologie, Praha 2, Not set
Hopital Henri Mondor, Creteil, Not set
Hôpital E. Muller, Mulhouse, Not set
Hopital Necker Enfants Malades, Paris cedex 15, Not set
HOPITAL SAINT LOUIS - Hematology / Oncology, Paris, Not set
Hopital Haut Leveque Service Maladie Du Sang, Pessac, Not set
CH LYON SUD - Hematology, Pierre Benite, Not set
CHU de Tours, Tours, Not set
Vivantes Klinikum Spandau-Klinik f. Innere Medizin Hämatologie/Onkologie/Gastroenterologie - Germany, Berlin, Not set
Universitätsklinikum Carl Gustav Carus; Med. Klinik und Poliklinik I - Hämatologische Ambulanz, Haus, Dresden, Not set
Universitätsklinikum Essen; Klinik f. Hämatologie- Germany, Essen, Not set
Justus-Liebig-Universitaet - Medizinische Klinik IV, Haematologie, Gießen, Not set
Universitätsklinikum Heidelberg Med. Klinik IV, Heidelberg, Not set
Universitätsklinikum des Saarlandes, Homburg/Saar, Not set
Gemeinschaftspraxis Dres. Uhle/Müller/Kröning/Jentsch-Ullrich - Germany, Magdeburg, Not set
OnkoNet Marburg GmbH, Marburg, Not set
Universitätsklinikum für Innere Med. III_Hämatologie, Onkologie...- Germany, Ulm, Not set
Laiko General Hospital - 1st department of Internal Medicine, Athens, Not set
G Papanikolaou Hospital of Thessaloniki, Thessalonikis, Not set
Semmelweis Egyetem, I. Belgyogyaszati Klinika, Budapest N/a, Not set
Szegedi Tudomanyegyetem II. Belgyogyaszati Klinika, Szeged, Not set
St James's Hospital, Dublin, Not set
Haemek Medical Center, Afula, Not set
Hillel Yaffe Medical Center - Oncology, Hadera, Not set
Rambam Health Care Campus, Haifa, Not set
Rabin Medical Center Beilinson Campus, Petah Tikva, Not set
Sheba Medical Center, Ramat-Gan, Not set
Tel Aviv Sourasky Medical Center, Tel Aviv, Not set
ASST Grande Ospedale Metropolitano Niguarda, Milano, Not set
DIPARTIMENTO DI BIOTECNOLOGIE CELLULARI ED EMATOLOGIA - UNIVERSITà ''LA SAPIENZA'', Roma, Not set
A.O.Citta della Salute e della Scienza di Torino, Torino, Not set
Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Bunkyo ku, Not set
Hiroshima University Hospital, Hiroshima shi, Not set
Hokkaido University Hospital, Sapporo-shi, Not set
National Cancer Center, Goyang-Si, Not set
The Catholic University of Korea Seoul St Mary s Hospital, Seoul, Not set
Oaxaca Site Management Organization S.C., Oaxaca, Not set
VU medisch centrum - Afd.Interne - INT, Amsterdam, Not set
Szpital Specjalistyczny w Brzozowie Podkarpacki Osrodek Onkologiczny im Ks B Markiewicza, Brzozow, Not set
Samodzielny Publiczny Zaklad Opieki Zdrowotnej Zespol Szpitali Miejskich, Chorzow, Not set
Uniwersyteckie Centrum Kliniczne, Gdansk, Not set
Pratia MCM Krakow, Krakow, Not set
Oddzial Hematologii, Opole, Not set
Wojewodzki Szpital Specjalistyczny im. Janusza Korczaka, Slupsk, Not set
Katedra I Klinika Hematologii Nowotworow Krwi I Transplantacji Szpiku, Wroclaw, Not set
Instituto Portugues de Oncologia, Lisboa, Not set
Hospital De Santa Maria, Lisbon, Not set
Instituto Portugues de Oncologia, Porto, Not set
Auxilio Mutuo Cancer Center, San Juan, Not set
Arkhangelsk Regional Clinical Hospital, Arkhangelsk, Not set
Chelyabinsk Regiona Onc. Center, Chelyabinsk, Not set
Emergency Hospital of Dzerzhinsk, Dzerzhinsk, Not set
Cancer Research Center, Moscow N/a, Not set
S.P. Botkin Moscow City Clinical Hospital, Moscow, Not set
Regional Clinical Hospital n.a.Semashko, Nizhni Novgorod, Not set
Medical Scientific Radiology - Center, Obninsk, Not set
Perm Medical Sanitary Unit#1, Perm, Not set
Republican Hospital named by V.A.Baranova, Petrozavodsk, Not set
Rostov Research Institute of Oncology, Rostov-Na-Donu, Not set
Ryazan Regional Clinical Hospital, Ryazan, Not set
Leningrad region clinical hospital, Saint, Not set
Samara Region Clinical Hospital, Samara, Not set
Federal Center of Heart, Blood and Endocrinology, Sankt-Peterburg, Not set
Oncological dispensary #2, Sochi, Not set
City Clinical Oncology Dispensary, St. Petersburg, Not set
Clinical Research Institute of Hematology and Transfusiology, St.-Petersburg, Not set
Oncology Dispensary of Komi Republic, Syktyvkar, Not set
Hospital Vall d'Hebron, Barcelona N/a, Not set
Inst. Cat. Doncologia-H Duran I Reynals, L'hospitalet De Llobregat, Not set
Hosp. Univ. de La Princesa, Madrid, Not set
Hosp. Gral. Univ. Gregorio Maranon, Madrid, Not set
Hosp. Univ. Infanta Leonor, Madrid, Not set
Fundacion Jimenez Diaz, Madrid, Not set
Clinica Universitaria de Navarra, Pamplona N/a, Not set
Hospital Clinico Universitario Salamanca, Salamanca, Not set
Sahlgrenska University hospital, Hematology Dept, Göteborg, Not set
Skanes universitetssjukhus, Lund, Not set
Karolinska Universitetssjukhuset Solna, Centrum för Hematologi, Stockholm, Stockholm, Not set
Changhua Cristian Hospital, Changhua County, Not set
Ankara University, Ankara, Not set
American Hospital, Istanbul, Not set
Istanbul University, Istanbul, Not set
Dokuz Eylul Universitesi Tip Fakultesi, Izmir, Not set
Erciyes University, Kayseri, Not set
Communal Nonprofit Enterprise 'Cherkasy Regional Oncology Dispensary Of Cherkasy Regional Council', Cherkasy, Not set
Dnepropetrovsk City Clinical Hospital #4, Regional Hematology Center, Dnepropetrovsk, Not set
SI Grigoriev Institute for Medical Radiology National Academy of Medical Science of Ukraine, Kharkiv, Not set
Khmelnitskiy Regional Hospital, Hematology Department, Khmelnitskiy, Not set
State Institution Scientific Center for Radiation Medicine Academy of Medical Sciences of Ukraine, Kiev, Not set
Institute of Blood Pathology and Transfusion Medicine of AMS of Ukraine, Lviv, Not set
Vinnytsya Regional Clinical Hospital named after M.I.Pirogov, Vinnitsa, Not set
University Hospitals Birmingham NHS Trust,, Birmingham, Not set
Royal Bournemouth Hospital, Bournemouth, Not set
Colchester Hospital University NHS, Colchester, Not set
Beatson West Of Scotland Cancer Centre, Glasgow, Not set
St James's Institute of Oncology, Leeds, Not set
Leicester Royal Infirmary - Haematology, Leicester, Not set
St Bartholomew's Hospital - Dept of Haematology, London, Not set
University College London Hospitals NHSFT, London, Not set
Kings College Hospital, London, Not set
Christie Hospital, Manchester, Not set
Nottingham University Hospitals NHS Trust, Nottingham, Not set
Derriford Hospital, Plymouth, Not set
Royal Hallamshire Hospital, Sheffield, Not set
Southampton General Hospital, Southampton, Not set
Royal Marsden Hospital (Sutton), Sutton, Not set
Conditions: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma, Diffuse Large B-cell Lymphoma, Waldenstrom Macroglobulinemia, Chronic Graft Versus Host Disease
A Study of Zilovertamab Vedotin (MK-2140) as Monotherapy and in Combination in Participants With Aggressive and Indolent B-cell Malignancies (MK-2140-006)
Recruiting
The purpose of this study is to assess the safety and tolerability of zilovertamab vedotin as monotherapy and in combination in participants with select B-cell lymphomas including mantle cell lymphoma (MCL), Richter's transformation lymphoma (RTL), follicular lymphoma (FL), and chronic lymphocytic leukemia (CLL). This study will also evaluate zilovertamab vedotin as monotherapy and in combination with respect to objective response rate.
* Cohort A: Participants with relapsed or refractory MCL r... Read More
The purpose of this study is to assess the safety and tolerability of zilovertamab vedotin as monotherapy and in combination in participants with select B-cell lymphomas including mantle cell lymphoma (MCL), Richter's transformation lymphoma (RTL), follicular lymphoma (FL), and chronic lymphocytic leukemia (CLL). This study will also evaluate zilovertamab vedotin as monotherapy and in combination with respect to objective response rate.
* Cohort A: Participants with relapsed or refractory MCL relapsed or refractory disease after at least 2 prior systemic therapies including a Bruton's tyrosine kinase inhibition/inhibitor (BTKi), and post therapy chimeric antigen receptor T (CAR-T) cell therapy or ineligible for CAR-T cell therapy
* Cohort B: Participants with relapsed or refractory RT disease after at least 1 prior systemic therapy
* Cohort C: Participants with relapsed or refractory MCL relapsed or refractory disease after at least 1 prior systemic therapy and no prior exposure to a non-covalent BTKi
* Cohort D: Participants with relapsed or refractory FL and CLL relapsed or refractory disease after at least 2 prior systemic therapies and have no other available therapy
* Cohort E: Participants with relapsed or refractory FL after at least 2 prior systemic therapies and have no other available therapy
The primary study hypothesis is that zilovertamab vedotin monotherapy has an increased Objective Response Rate (ORR) per Lugano Response Criteria as assessed by blinded independent central review (BICR).
As of Amendment 07, Cohort D is closed to enrollment of participants with CLL and enrollment of participants into Arm 2 (zilovertamab vedotin at Dose 2 on Days 1 \& 8 of each 3 Week Cycle (Q2/3W)). Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
08/14/2025
Locations: Alaska Oncology and Hematology ( Site 0037), Anchorage, Alaska +108 locations
Alaska Oncology and Hematology ( Site 0037), Anchorage, Alaska
Banner MD Anderson Cancer Center ( Site 0040), Gilbert, Arizona
Banner MD Anderson Cancer Center - University Medical Center Phoenix-Medical Oncology ( Site 0036), Phoenix, Arizona
University of Colorado Anschutz Medical Campus-The Center for Cancer and Blood Disorders ( Site 0008), Aurora, Colorado
Cancer Care Specialists of Illinois ( Site 0031), Decatur, Illinois
University of Kansas Medical Center-Division of Hematologic Malignancies and Cellular Therapeutics ( Site 0038), Fairway, Kansas
Norton Women's and Children's Hospital-Norton Cancer Institute - St. Matthews ( Site 0007), Saint Matthews, Kentucky
Greenebaum Comprehensive Cancer Center-Hematology & Multiple Myeloma ( Site 0010), Baltimore, Maryland
Tufts Medical Center ( Site 0024), Boston, Massachusetts
Massachusetts General Hospital ( Site 0018), Boston, Massachusetts
Dana-Farber Cancer Institute-Lymphoma ( Site 0026), Boston, Massachusetts
University of Michigan ( Site 0009), Ann Arbor, Michigan
Henry Ford Hospital ( Site 0035), Detroit, Michigan
Icahn School of Medicine at Mount Sinai ( Site 0023), New York, New York
Sanford Fargo Medical Center-Roger Maris Cancer Center ( Site 0014), Fargo, North Dakota
The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive C ( Site 0004), Columbus, Ohio
Avera Cancer Institute- Research ( Site 0011), Sioux Falls, South Dakota
Medical Oncology Associates, PS ( Site 0005), Spokane, Washington
University of Wisconsin Hospitals and Clinics-Carbone Cancer Center ( Site 0030), Madison, Wisconsin
MEDICAL COLLEGE OF WISCONSIN ( Site 0021), Milwaukee, Wisconsin
Liga Norte Riograndense Contra o Câncer-Centro de Pesquisa Clínica ( Site 1807), Natal, Rio Grande Do Norte
Instituto Nacional de Câncer - INCA-Divisão de Pesquisa Clínica e Desenvolvimento Tecnológico HC1 ( Site 1809), Rio de Janeiro, Not set
ICESP - INSTITUTO DO CÂNCER DO ESTADO DE SÃO PAULO ( Site 1808), Sao Paulo, Not set
Hospital Paulistano-Americas Oncologia ( Site 1805), Sao Paulo, Not set
BC Cancer Vancouver-Clinical Trials Unit ( Site 0201), Vancouver, British Columbia
The Moncton Hospital-Oncology ( Site 0211), Moncton, New Brunswick
QEII Health Sciences Centre - Victoria General Site ( Site 0213), Halifax, Nova Scotia
Lawson Health Research Institute - London Health Sciences Ce-London Regional Cancer Program ( Site 0203), London, Ontario
Princess Margaret Cancer Centre-Division of Medical Oncology and Hematology ( Site 0200), Toronto, Ontario
Jewish General Hospital ( Site 0202), Montreal, Quebec
Allan Blair Cancer Centre-Care Services ( Site 0208), Regina, Saskatchewan
IC La Serena Research ( Site 1909), La Serena., Coquimbo
Centro de Estudios Clínicos SAGA-CECSAGA ( Site 1907), Santiago., Region M. De Santiago
Clínica Inmunocel ( Site 1910), Santiago, Region M. De Santiago
Clínica Alemana de Santiago ( Site 1903), Santiago, Region M. De Santiago
Beijing Cancer hospital ( Site 1200), Beijing, Beijing
Zhujiang Hospital ( Site 1207), Guangzhou, Guangdong
Southern Medical University Nanfang Hospital ( Site 1202), Guangzhou, Guangdong
Sun Yat-sen University Cancer Center ( Site 1201), Guangzhou, Guangdong
Henan Cancer Hospital-hematology department ( Site 1212), Zhengzhou, Henan
Union Hospital Tongji Medical College Huazhong University of Science and Technology ( Site 1210), Wuhan, Hubei
Tongji Hospital Tongji Medical,Science & Technology ( Site 1221), Wuhan, Hubei
The First Affiliated Hospital of Soochow University-hematology department ( Site 1218), Suzhou, Jiangsu
The Affiliated Hospital of Xuzhou Medical College ( Site 1223), Xuzhou, Jiangsu
The First Affiliated Hospital of Nanchang University ( Site 1204), Nanchang, Jiangxi
Jiangxi Provincial Cancer Hospital ( Site 1213), Nanchang, Jiangxi
Jilin Province Tumor Hospital-oncology department ( Site 1220), Chuangchun, Jilin
Fudan University Shanghai Cancer Center ( Site 1208), Shanghai, Shanghai
West China Hospital of Sichuan University-Head and Neck Oncology ( Site 1206), Cheng Du, Sichuan
The First Affiliated Hospital, Zhejiang University ( Site 1211), Hangzhou, Zhejiang
Zhejiang Cancer Hospital ( Site 1214), Hangzhou, Zhejiang
Fakultní nemocnice Brno Bohunice-Interni hematologicka a onkologicka klinika ( Site 0300), Brno, Brno-mesto
Fakultni nemocnice Ostrava-Klinika Hematoonkologie ( Site 0301), Ostrava, Moravskoslezsky Kraj
Vseobecna fakultni nemocnice v Praze-I. Interní klinika - klinika hematologie ( Site 0302), Praha 2, Not set
North Estonia Medical Centre Foundation ( Site 0401), Tallinn, Harjumaa
Universitaetsklinikum Ulm. ( Site 0502), Ulm, Baden-Wurttemberg
Universitaetsklinikum Koeln ( Site 0506), Köln, Nordrhein-Westfalen
St. James's Hospital ( Site 0600), Dublin, Not set
Emek Medical Center-Hematology Unit ( Site 0705), Afula, Not set
Soroka Medical Center-Hematology Department ( Site 0707), Be'er Sheva, Not set
Rambam Health Care Campus-Hematology and Bone Marrow Transplantation ( Site 0706), Haifa, Not set
Carmel Hospital ( Site 0709), Haifa, Not set
Hadassah Medical Center ( Site 0701), Jerusalem, Not set
Galilee Medical Center ( Site 0710), Nahariya, Not set
Sheba Medical Center-Hemato Oncology ( Site 0700), Ramat Gan, Not set
IRCCS - AOU di Bologna-SSD: Diagnosi e terapie dei linfomi e delle sindromi linfoproliferative cron ( Site 0800), Bologna, Emilia-Romagna
Humanitas-U.O di Oncologia medica ed Ematologia ( Site 0802), Rozzano, Milano
Azienda Ospedaliera Nazionale SS. Antonio e Biagio e Cesare -Azienda Ospedaliera Nazionale SS. Ant ( Site 0803), Alessandria, Not set
Fondazione Policlinico Universitario Agostino Gemelli IRCCS -ISTITUTO DI EMATOLOGIA ( Site 0804), Roma, Not set
National Hospital Organization Nagoya Medical Center ( Site 1108), Nagoya, Aichi
Hokkaido University Hospital ( Site 1104), Sapporo, Hokkaido
Tokai University Hospital ( Site 1100), Isehara, Kanagawa
Tohoku University Hospital ( Site 1106), Sendai-shi, Miyagi
Kindai University Hospital ( Site 1102), Sayama, Osaka
National Cancer Center Hospital ( Site 1103), Chuo-ku, Tokyo
Cancer Institute Hospital of JFCR ( Site 1101), Koto, Tokyo
Kyushu University Hospital ( Site 1105), Fukuoka, Not set
Okayama University Hospital ( Site 1107), Okayama, Not set
Seoul National University Hospital ( Site 1300), Seoul, Not set
Samsung Medical Center ( Site 1301), Seoul, Not set
Centro Medico Monte Carmelo ( Site 1702), Arequipa, Ariqipa
INSTITUTO NACIONAL DE ENFERMEDADES NEOPLASICAS ( Site 1700), Lima, Not set
Wojewodzkie Wielospecjalistyczne Centrum Onkologii i Traumat-Oddiał Hematologii Ogólnej ( Site 1008), Łódź, Lodzkie
Centrum Onkologii Ziemi Lubelskiej-Oddzial Hematologiczny ( Site 1006), Lublin, Lubelskie
Pratia MCM Krakow ( Site 1001), Krakow, Malopolskie
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Klinika Nowotworów Układu Chłonnego ( Site 1002), Warszawa, Mazowieckie
Swietokrzyskie Centrum Onkologii, Samodzielny Publiczny Zakl-Klinika Hematologii i Transplantacji S ( Site 1010), Kielce, Swietokrzyskie
Samodzielny Publiczny Zakład Opieki Zdrowotnej MSWiA w Olsztynie-Oddzial Kliniczny Hematologii ( Site 1007), Olsztyn, Warminsko-mazurskie
Champalimaud Foundation ( Site 2002), Lisbon, Lisboa
Unidade Local de Saude de Braga - Hospital de Braga ( Site 2001), Braga, Not set
Instituto Português de Oncologia do Porto Francisco Gentil, EPE ( Site 2000), Porto, Not set
National Cancer Centre Singapore ( Site 1500), Singapore, Central Singapore
Instituto Catalan de Oncologia - Hospital Duran i Reynals-Haematology Department ( Site 4003), L'Hospitalet Del Llobregat, Barcelona
Hospital Universitari Vall d'Hebron ( Site 4004), Barcelona, Cataluna
MD Anderson Cancer Center ( Site 4006), Madrid, Madrid, Comunidad De
Clinica Universidad de Navarra ( Site 4005), Pamplona, Navarra
Hospital Universitario de Salamanca - Complejo Asistencial Universitario de Salamanca-Hematology ( Site 4001), Salamanca, Not set
Skånes Universitetssjukhus Lund ( Site 5000), Lund, Skane Lan
Akademiska sjukhuset-Blod- och tumörsjukdomar ( Site 5002), Uppsala, Uppsala Lan
Sahlgrenska Universitetssjukhuset ( Site 5003), Gothenburg, Vastra Gotalands Lan
Mega Medipol-Hematology ( Site 6009), Stanbul, Istanbul
Ankara Universitesi Tip Fakultesi Hastanesi-hematology ( Site 6001), Ankara, Not set
Trakya University ( Site 6005), Edirne, Not set
Ege Universitesi Hastanesi ( Site 6002), İzmir, Not set
Ondokuz Mayıs Universitesi-Oncology department ( Site 6004), Samsun, Not set
The Royal Cornwall Hospital-Haematology ( Site 7006), Truro, Cornwall
University College London Hospital ( Site 7001), London, London, City Of
The Churchill Hospital ( Site 7002), Oxford, Oxfordshire
The Christie NHS Foundation Trust ( Site 7007), Manchester, Not set
Conditions: Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Follicular Lymphoma, Richter Transformation Lymphoma
A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab + Lenalidomide (+Len), and the Safety, Tolerability, and Pharmacokinetics of SC Versus IV Mosunetuzumab + Len in Participants With Follicular Lymphoma
Recruiting
This study will evaluate the safety, efficacy, pharmacokinetics, and immunogenicity of mosunetuzumab (Mosun) + lenalidomide (Len) (Mosun + Len) in participants with follicular lymphoma (FL). This study will also compare the pharmacokinetics, pharmacodynamics, safety, efficacy, and immunogenicity of IV mosunetuzumab + len vs subcutaneous (SC) mosunetuzumab + len.
This study will evaluate the safety, efficacy, pharmacokinetics, and immunogenicity of mosunetuzumab (Mosun) + lenalidomide (Len) (Mosun + Len) in participants with follicular lymphoma (FL). This study will also compare the pharmacokinetics, pharmacodynamics, safety, efficacy, and immunogenicity of IV mosunetuzumab + len vs subcutaneous (SC) mosunetuzumab + len. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
08/01/2025
Locations: City of Hope National Medical Center, Duarte, California +27 locations
City of Hope National Medical Center, Duarte, California
Fairview Hospital, Cleveland, Ohio
Cleveland Clinic, Cleveland, Ohio
Hillcrest Hospital, Mayfield Heights, Ohio
Tennessee Oncology;Chattanooga Oncology & Hematology Associates, Chattanooga, Tennessee
Tennessee Oncology PLLC - Franklin, Franklin, Tennessee
Swedish Medical Center, Seattle, Washington
the First Hospital of Jilin University, Changchun, Not set
Hunan Cancer Hospital, Changsha City, Not set
West China Hospital, Sichuan University, Chengdu, Not set
Fudan University Shanghai Cancer Center, Shanghai City, Not set
Tianjin Medical University Cancer Institute & Hospital, Tianjing, Not set
The First Affiliated Hospital of Xiamen University, Xiamen, Not set
CHRU de Lille - Hopital Claude Huriez, Lille, Not set
CHU Montpellier, Montpellier, Not set
Hôpital Saint-Louis, Paris, Not set
Centre Hospitalier Lyon Sud, Pierre Benite, Not set
CHU Rennes - Hopital Pontchaillou, Rennes cedex 09, Not set
Institut Claudius Regaud, Toulouse, Not set
Hospital Universitario Vall d Hebron, Barcelona, Not set
Hospital Universitario Fundacion Jimenez Diaz., Madrid, Not set
Hospital Universitario Virgen de la Victoria, Malaga, Not set
Complejo Asistencial Universitario de Salamanca, Salamanca, Not set
University College London Hospitals NHS Foundation Trust - University College Hospital, London, Not set
The Christie NHS Foundation Trust, Manchester, Not set
Freeman Hospital, Newcastle upon Tyne, Not set
Nottingham University Hospitals NHS Trust - City Hospital, Nottingham, Not set
Oxford University Hospitals NHS Foundation Trust, Oxford, Not set
Conditions: Follicular Lymphoma
A Study to Assess the Efficacy, Safety, Pharmacodynamics, and Pharmacokinetics of Tazemetostat in Combination With Lenalidomide Plus Rituximab Versus Placebo in Combination With Lenalidomide Plus Rituximab in Adult Patients at Least 18 Years of Age With Relapsed/Refractory Follicular Lymphoma.
Recruiting
The participants of this study would have relapsed/refractory follicular lymphoma.
Follicular lymphoma is a type of blood cancer. It is referred to as 'relapsed' when the disease has come back after a period of improvement after that follows a treatment regimen and 'refractory' when treatment no longer works.
Stage 1 of this trial will study the safety and the level that adverse effects of each of the study drug combinations can be tolerated (known as tolerability). It is also designed to esta... Read More
The participants of this study would have relapsed/refractory follicular lymphoma.
Follicular lymphoma is a type of blood cancer. It is referred to as 'relapsed' when the disease has come back after a period of improvement after that follows a treatment regimen and 'refractory' when treatment no longer works.
Stage 1 of this trial will study the safety and the level that adverse effects of each of the study drug combinations can be tolerated (known as tolerability). It is also designed to establish a recommended study drug dosage for stage 2 and 3. Stage 1 of the study is completed.
Stages 2 and 3 will evaluate and compare how long participants live without their disease getting worse when receiving the study drug in combination with other drug treatment versus the placebo (dummy drug) in combination with other drug treatment. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/31/2025
Locations: Southern Cancer Center, Mobile, Alabama +208 locations
Southern Cancer Center, Mobile, Alabama
Arizona Oncology Associates - Tuscon-Rusadill Road, Tucson, Arizona
TOI - Clinical Research, Cerritos, California
UCSF Fresno, Clovis, California
UC San Diego Health Sciences, La Jolla, California
UCLA Clinical Research Unit Hematology/Oncology, Santa Monica, California
Rocky Mountain Cancer Centers (RMCC) - Boulder, Boulder, Colorado
St. Mary's Hospital and Regional Medical Center - St. Mary's, Grand Junction, Colorado
SCL Health Lutheran Medical Center, Greeley, Colorado
Cancer Specialists of North Florida, Fleming Island, Florida
Florida Cancer Specialists & Research Institute (FCS) - Fort Myers Cancer Center, Fort Myers, Florida
Mayo Clinic - Cancer Clinical Research Office, Jacksonville, Florida
Mayo Clinic, Jacksonville, Florida
Miami Cancer Institute, Miami, Florida
Florida Cancer Affiliates/Ocala Oncology - Clinic, Ocala, Florida
BRCR Medical Center, INC, Plantation, Florida
Florida Cancer Specialists, Saint Petersburg, Florida
Florida Cancer Specialists - Panhandle, Tallahassee, Florida
H Lee Moffitt Cancer Center and Research Institute I, Tampa, Florida
Florida Cancer Specialists & Research Institute (FCS) - Atlantis, West Palm Beach, Florida
Kaiser Permanente Hawaii Moanalua Medical Center, Honolulu, Hawaii
University of Chicago, Chicago, Illinois
Illinois Cancer Specialists, Niles, Illinois
June E. Nylen Cancer Center, Sioux City, Iowa
The University of Kansas Cancer Center, Overland Park, Kansas
University of Maryland, Baltimore, Maryland
The office of Frederick P. Smith, MD, P.C., Chevy Chase, Maryland
Mass General Cancer Center at Newton-Wellesley, Newton, Massachusetts
University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan
St. Joseph Mercy Hospital, Ypsilanti, Michigan
Mayo Clinic - Rochester, Rochester, Minnesota
Saint Louis University Cancer Center, Saint Louis, Missouri
University Of Nebraska Medical Center, Omaha, Nebraska
Astera Cancer Care, East Brunswick, New Jersey
Astera Cancer Center, East Brunswick, New Jersey
Regional Cancer Care Associates-Freehold, Freehold, New Jersey
Hackensack University Medical John Theurer Cancer Center, Hackensack, New Jersey
Regional Cancer Care Associates LLC - Howell, Howell, New Jersey
Regional Cancer Care Associates LLC - Little Silver, Little Silver, New Jersey
New Mexico Cancer Care Alliance, Albuquerque, New Mexico
New York Oncology Hematology, P.C., Albany, New York
Northwell Health/Monter Cancer Center, Lake Success, New York
Weill Cornell Medicine-New York Presbyterian Hospital, New York, New York
Columbia U - Herbert Irving Comprehensive Cancer Center, New York, New York
Memorial Sloan-Kettering Cancer Center, New York, New York
Hematology Oncology Associates of Rockland, P.C., Nyack, New York
Messino Cancer Center, Asheville, North Carolina
Levine Cancer Institute - Concord, Concord, North Carolina
FirstHealth of the Carolinas, Pinehurst, North Carolina
Gabrail Cancer Center Research, Canton, Ohio
Oncology Hematology Care (OHC), Inc. - Kenwood Office, Cincinnati, Ohio
Willamette Valley Cancer Institute and Research Center - Oncology, Eugene, Oregon
University of Pittsburgh Medical Center - Oncology, Pittsburgh, Pennsylvania
Western Pennsylvania Hospital Hematology & Cellular Therapy, Pittsburgh, Pennsylvania
Tennessee Oncology, PLLC, Chattanooga, Tennessee
University of Tennessee Medical Center - Cancer Institute, Knoxville, Tennessee
Sarah Cannon Research Institute, Nashville, Tennessee
Texas Oncology - Amarillo, Amarillo, Texas
Texas Oncology-Austin Midtown, Austin, Texas
Texas Oncology - Medical City Dallas Pediatric Hematology, Dallas, Texas
Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, Texas
The University of Texas MD Anderson Cancer Center, Houston, Texas
Millennium Physicians - Oncology, Houston, Texas
Texas Oncology, Plano, Texas
Mays Cancer Center, San Antonio, Texas
UT Health East Texas HOPE Cancer Center - Tyler, Tyler, Texas
USO Texas Oncology - Tyler, Tyler, Texas
Texas Oncology- Weslaco, Weslaco, Texas
Utah Cancer Specialists/ IHO Corp, Salt Lake City, Utah
Huntsman Cancer Institute; The University of Utah, Salt Lake City, Utah
Peninsula Cancer Institute, Chesapeake, Virginia
Virginia Cancer Specialists, Gainesville, Virginia
Oncology and Hematology Associates of Southwest Virginia Inc., Roanoke, Virginia
MC Rockwood Cancer Bl Specialty Ctr - North, Spokane, Washington
Yakima Valley Memorial Hospital - North Star Lodge Cancer Center, Yakima, Washington
Wheeling Hospital, Wheeling, West Virginia
Royal Adelaide Hospital, Adelaide, South Australia
Flinders Medical Centre, Bedford Park, South Australia
Monash Health, Clayton, Victoria
Barwon Health, University Hospital Geelong, Geelong, Victoria
Hollywood Private Hospital, Nedlands, Western Australia
GenesisCare - St Andrew's, Adelaide, Not set
Peninsula Health - Frankston, Frankston, Not set
Royal Hobart Hospital, Hobart, Not set
Gold Coast University Hosptial, Southport, Not set
CHU Dinant Godinne UCL Namur, Yvoir, Namur
Universitair Ziekenhuis Gent, Gent, Oost-Vlaanderen
UZ Leuven - Campus Gasthuisberg, Leuven, Vlaams Brabant
University Health Network Princess Margaret Hospital, Toronto, Ontario
Centre Hospitalier de l'Universite de Montreal (CHUM), Montréal, Quebec
Sir Mortimer B Davis/Jewish General Hospital, Montréal, Quebec
Fujian Medical University Union Hospital, Fuzhou, Fujian
The First Affiliated Hospital of Xiamen University, Xiamen, Fujian
The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou
The Second Affiliated Hospital Zhejiang University School of Medicine, Zhejiang, Hangzhou
The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei
Henan Provincial People's Hospital, Zhengzhou, Henan
Henan Cancer Hospital, Zhengzhou, Henan
Hunan Cancer Hospital, Changsha, Hunan
The First Bethune Hospital of Jilin University, Changchun, Jinlin
The Affiliated Hospital of Qingdao University, Qingdao, Shandong
Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, Shanghai
Shanxi Bethune Hospital, Taiyuan, Shanxi
Peking University Third Hospital, Beijing, Not set
Tongji Hospital of Tongji Medical College of HUST, Hangzhou, Not set
Jiangxi Cancer Hospital, Nanchang, Not set
Shandong Cancer Hospital, Shandong, Not set
Tongji Hospital of Tongji University, Shanghai, Not set
Sichuan Provincial People's Hospital, Sichuan, Not set
Tianjin Medical University Cancer Institute & Hospital, Tianjin, Not set
Centre Hospitalier Universitaire de Bordeaux-Hopital du Haut Leveque, Pessac Cedex, Aquitaine
CHRU Brest Hôp Morvan, Brest, Bretagne
Institut Bergonie, Bordeaux, Gironde
Centre Hosp Mulh Hop Emile Muller, Mulhouse, Haut-Rhin
Centre Henri Becquerel, Rouen, Haute-Normandie
CHU de Limoges Dupuytren, Limoges, Haute-Vienne
CHU de Grenoble - Hopital Albe, La Tronche, Isere
CHU de Nantes - Hematologie, Nantes, Loire-Atlantique
CHRU de Lille Hop Claude Huriez, Lille, Nord
Centre Hospitalier Le Mans, Le Mans, Sarthe
Centre Hospitalier Universitaire D'Angers - Hématologie Clinique, Angers, Not set
CHRU de Besançon- Hopital Jean Minjoz, Besancon, Not set
CHU Caen, Caen, Not set
CHU de Clermont-Ferrand, site Estaing, Clermont-Ferrand, Not set
Centre Hospitalier Docteur Schaffner, Lens, Not set
L'Hôpital Privé Confluent, Nantes, Not set
L'hôpital Privé du Concluent, Nantes, Not set
Hopital Saint Louis, Paris, Not set
Centre Hospitalier Universitaire de Poitiers, Poitiers, Not set
Centre Hospitalier - Hôpital de jour d'Hématologie, Périgueux, Not set
CHU de Nancy Brabois, Vandœuvre-lès-Nancy, Not set
Centre Hospitalier Bretagne Atlantique, Vannes, Not set
Institut Gustave Roussy, Villejuif, Not set
Hopital Henri Mondor - Hemopathies Lymphoides, Créteil, Île-de-France
Diakoneo Diak Schwaebisch Hall gGmbH, Schwäbisch Hall, Baden-Württemberg
Klinikum Der Universität München AöR, München, Bayern
Klinikum rechts der Isar der Technischen Universitat Muenche, München, Bayern
Universitätsmedizin Mainz, Mainz, Hessen
Universitaetsklinikum Bonn AöR, Bonn, Nordrhein-Westfalen
Kliniken Maria Hilf GmbH, Moenchengladbach, Nordrhein-Westfalen
Städt. Krankenhaus Kiel, Kiel, Schleswig-Holstein
Vivantes Klinikum am Urban Hämatologie und Onkologie, Berlin, Not set
University Medical Center Schleswig Holstein, Kiel, Not set
Debreceni Egyetem Klinikai Központ, Debrecen, Hajdú-Bihar
Semmelweis Egyetem Általános Orvostudományi Kar, Budapest, Not set
Országos Onkológiai Intézet, Budapest, Not set
Del-pesti Centrumkorhaz Orszagos Hematologiai és Infektologiai Intezet, Budapest, Not set
AOU Federico II, Napoli, Campania
Istituto Romagnolo per lo Studio dei Tumori (IRST) Dino Amadori IRCCS, Meldola, Forli-Cesena
ASST Spedali Civili di Brescia, Brescia, Not set
PO Garibaldi-Nesima, ARNAS Garibaldi, Catania, Not set
AOU Careggi, Firenze, Not set
Ospedale Vito Fazzi, ASL Lecce, Lecce, Not set
IEO - Istituto Europeo di Oncologia, IRCCS, Milano, Not set
Ospedale Maggiore Policlinico, Fondazione IRCCS Ca' Granda, Milano, Not set
Ospedale Niguarda, ASST Grande Ospedale Metropolitano Niguarda, Milano, Not set
Ospedale San Gerardo, ASST di Monza, Monza, Not set
Ospedale Civile S.Spirito, PO di Pescara, AUSL Pescara, Pescara, Not set
Ospedale Infermi di Rimini, AUSL Rimini, Distretto di Rimini, Presidio di Rimini, Santarcangelo di Romagna e Novafeltria, Rimini, Not set
Catholic University Of Sacred Heart, Roma, Not set
PU Campus Bio-Medico di Roma, Roma, Not set
Regina Elena, Istituto Nazionale dei Tumori , IFO, IRCCS, Roma, Not set
Azienda Ospedaliera Santa Maria di Terni, Terni, Not set
Azienda Ospedaliera Ordine Mauriziano di Torino, Ospedale Umberto I di Torino, Torino, Not set
Ospedale S.Giacomo Apostolo, PO Castelfranco Veneto, AULSS 2 Marca Trevigiana, Treviso, Not set
Azienda Sanitaria Universitaria Giuliano Isontina (ASU GI), Ospedale Maggiore, Trieste, Not set
The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul, Seoul Teugbyeolsi [Seoul-T'ukp]
Severance Hospital, Yonsei University Health System, Seoul, Seoul Teugbyeolsi [Seoul-T'ukp
Samsung Medical Center, Seoul, Seoul Teugbyeolsi [Seoul-T'ukp
Seoul National University Hospital, Seoul, Seoul Teugbyeolsi
Pusan National University Hospital, Busan, Not set
Gachon University Gil Medical Center, Incheon, Not set
Ajou University Hospital, Suwon, Not set
Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie - Państwowy Instytut Badawczy, Warszawa, Mazowieckie
Centrum Medyczne Pratia Poznan, Skorzewo, Wielkopolskie
Pratia Onkologia Katowice, Katowice, Not set
Pratia MCM Krakow, Kraków, Not set
Wojewodzki Szpital Specjalistyczny im. Janusza Korczaka w Slupsku Sp. z o.o., Słupsk, Not set
MICS Centrum Medyczne Torun, Torun, Not set
MTZ Clinical Research powered by Pratia, Warszawa, Not set
Uniwersytecki Szpital Kliniczny im. J. Mikulicza-Radeckiego we Wroclawiu, Wroclaw, Not set
National Cancer Center Singapore, Singapore, Not set
Hospital Universitari Vall d'Hebrón, Barcelona, Cataluny
Hospital Costa del Sol, Marbella, Málaga
Hospital Del Mar, Barcelona, Not set
Hospital Univ. Infanta Leonor, Madrid, Not set
Hospital Universitario La Paz, Madrid, Not set
Clínica Universidad de Navarra, Madrid, Not set
C.H. de Navarra, Pamplona, Not set
Hospital Universitario de Salamanca, Salamanca, Not set
Hospital Universitario Nuestra Señora de Valme, Sevilla, Not set
Hospital Universitario Virgen De La Macarena, Sevilla, Not set
Buddihist Tzu Chi Medical Foundation- Hualien Tzu Chi Hospital, Hualien City, Not set
Chang Gung Medical Foundation - Kaohsiung Chang Gung Memorial Hospital - Hemato-Oncology, Kaohsiung, Not set
Taichung Veterans General Hospital, Taichung, Not set
National Cheng Kung University Hospital, Tainan, Not set
National Taiwan University Hospital, Taipei, Not set
Ankara University Medical Faculty - Hematology, Ankara, Not set
Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research, Ankara, Not set
Gazi University Medical Faculty, Ankara, Not set
Medipol Bagcilar Mega Hospital, Istanbul, Not set
Ondokuz Mayis University Medical Faculty - Hematology, Samsun, Not set
Western General Hospital - Haematology, Edinburgh, Edinburgh, City Of
Imperial College Healthcare NHS Trust - Hammersmith Hospital, London, London City
St Bartholomew's Hospital Barts Health NHS Trust, London, London, City Of
The Clatterbridge Cancer Centre NHS Foundation Trust - Clatterbridge Cancer Centre, Bebington, Not set
Royal Cornwall Hospitals NHS Trust - Royal Cornwall Hospital, Cornwell, Not set
Beatson West of Scotland Cancer Centre, Glasgow, Not set
Northwick Park Hospital Middlesex, United Kindgom, HA1 3UJ, Middlesex, Not set
Conditions: Relapsed/Refractory Follicular Lymphoma, Follicular Lymphoma, Refractory Follicular Lymphoma
First in Human Study of NVG-111 in Relapsed/Refractory ROR1+ Malignancies
Recruiting
NVG-111 is a bispecific antibody drug, having two "arms", one arm attaches to a substance on cancer cells called ROR1, the other arm attaches to the body's immune cells directing them to kill the cancer cells. This is the first clinical trial of the drug NVG-111, and will include patients with certain types of cancer including chronic lymphocytic leukaemia (CLL), small lymphocytic lymphoma (SLL) mantle cell lymphoma (MCL), follicular lymphoma (FL) and diffuse large B cell lymphoma (DLBCL) in Gro... Read More
NVG-111 is a bispecific antibody drug, having two "arms", one arm attaches to a substance on cancer cells called ROR1, the other arm attaches to the body's immune cells directing them to kill the cancer cells. This is the first clinical trial of the drug NVG-111, and will include patients with certain types of cancer including chronic lymphocytic leukaemia (CLL), small lymphocytic lymphoma (SLL) mantle cell lymphoma (MCL), follicular lymphoma (FL) and diffuse large B cell lymphoma (DLBCL) in Group A. Subjects with solid tumours, focusing initially on stage IV non-small cell lung cancer (NSCLC) or malignant melanoma. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/05/2023
Locations: University College London Hospital, London, Not set +2 locations
University College London Hospital, London, Not set
Royal Marsden Hospital, London, Not set
The Christie NHS Foundation Trust, Manchester, Not set
Conditions: Chronic Lymphocytic Leukaemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma, Diffuse Large B Cell Lymphoma, Non-small Cell Lung Cancer (NSCLC), Malignant Melanoma
1 - 7 of 7
